Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
Oncotarget. 2017 Sep 23;8(50):87837-87847. doi: 10.18632/oncotarget.21237. eCollection 2017 Oct 20.
Oncotarget. 2017.
PMID: 29152124
Free PMC article.
A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer.
Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP.
Jacob H, et al. Among authors: hestetun ke.
Sci Rep. 2018 Apr 18;8(1):6157. doi: 10.1038/s41598-018-24519-4.
Sci Rep. 2018.
PMID: 29670141
Free PMC article.
Item in Clipboard
Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer.
Hestetun KE, Rosenlund NB, Stanisavljević L, Dahl O, Myklebust MP.
Hestetun KE, et al.
Front Oncol. 2022 Aug 30;12:853545. doi: 10.3389/fonc.2022.853545. eCollection 2022.
Front Oncol. 2022.
PMID: 36110945
Free PMC article.
Item in Clipboard
Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature.
Berle M, Hestetun KE, Vethe H, Chera S, Paulo JA, Dahl O, Myklebust MP.
Berle M, et al. Among authors: hestetun ke.
Cancer Genomics Proteomics. 2022 Mar-Apr;19(2):130-144. doi: 10.21873/cgp.20309.
Cancer Genomics Proteomics. 2022.
PMID: 35181583
Free PMC article.
Item in Clipboard
Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer.
Hestetun KE, Brydøy M, Myklebust MP, Dahl O.
Hestetun KE, et al.
Acta Oncol. 2015 Apr;54(4):470-9. doi: 10.3109/0284186X.2014.952386. Epub 2014 Sep 17.
Acta Oncol. 2015.
PMID: 25227897
Clinical Trial.
Item in Clipboard
Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer.
Hestetun KE, Aasebø K, Rosenlund NB, Müller Y, Dahl O, Myklebust MP.
Hestetun KE, et al.
Mod Pathol. 2021 Jan;34(1):161-170. doi: 10.1038/s41379-020-0634-9. Epub 2020 Jul 31.
Mod Pathol. 2021.
PMID: 32737450
Free article.
Item in Clipboard
Cite
Cite